Patent · US Active

Dosage form for use in treating or preventing of a disease

US11730708B2 · kind B2 · utility

0Cited by

4References

15Claims

0Family size

Assignee

Evonik Operations GmbH · DE

Inventors

Priyanka Bansilal Haksar · Thane, IN
Shraddha Joshi · Navi Mumbai, IN
Umesh Kapale · Solapur, IN
Nilam Bharambe · Gharivali, IN
Ashish Guha · Kalyan-Dombivli, IN
Vinay K. Jain · Dallas, US

Key dates

Filing date	Sep 17, 2020
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Sep 17, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dosage form contains a biologically active ingredient for treating or preventing a disease in the animal or human body, where the treatment or prevention requires release of 50% or more of the biologically active ingredient in the small intestine within the pH range from 3 to 5.5. The dosage form contains: a) a core, containing the biologically active ingredient; b) an intermediate coating layer (ICL) onto or above the core, containing an alkaline agent; and c) an enteric coating layer (ECL) onto or above the intermediate coating layer, containing an enteric polymer. The relation of the alkaline agent to the enteric polymer is 5 to 95% when calculated by the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.